查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933384

無菌檢測市場規模、佔有率、成長、全球產業分析：依類型、應用、區域洞察和預測（2026-2034 年）

Sterility Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 110 Pages | 商品交期: 請詢問到貨日

價格

無菌檢測市場成長因素

預計全球無菌檢測市場規模在 2025 年將達到 12.8 億美元，2026 年將成長至 13.8 億美元，最終在 2034 年達到 26.3 億美元，預測期內複合年增長率 (CAGR) 為 8.4%。北美地區在 2025 年佔市場主導地位，市佔率高達 39.79%。這主要得益於大規模的藥品生產、嚴格的監管架構以及無菌保證技術的進步。

無菌檢測是確保藥品、生物製藥和醫療器材中不含任何有害微生物的關鍵品質控制流程。 受生物製藥、疫苗和組合產品產量增加、監管機構對污染預防的日益重視以及快速微生物檢測方法 (RMM) 的日益普及的推動，市場正經歷強勁增長。默克集團 (Merck KGaA)、賽多利斯股份公司 (Sartorius AG)、SKAN AG、Getinge AB 和 Fedegari Autoclavi S.p.A. 等領先企業正透過產品創新和策略投資推動市場擴張。

市場動態

市場驅動因素

生物製藥日益複雜化和嚴格的安全法規

無菌生產流程日益複雜化，推動了對無菌檢測的需求。生物製劑、疫苗和先進治療藥物 (ATMP) 等先進療法需要經過驗證的方法、培養基填充檢測、隔離器系統和嚴格的污染控制。合約研發生產機構 (CDMO) 正在擴大產能並實施快速檢測方法，以加快產品上市速度。例如，2025年10月，禮來公司宣布投資超過10億美元，擴大在印度的生產設施，以滿足更嚴格的無菌要求。

市場限制

缺乏標準化和複雜的驗證程序

缺乏全球統一的無菌檢測方案給生產商帶來了挑戰。美國藥典（USP）、歐洲藥典（EP）和日本藥典（JP）之間的監管差異導致重複驗證工作、成本增加和產品上市延遲。快速微生物檢測方法需要進行大量的等效性和可比較性測試，這進一步增加了合規的難度。 例如，Brassica Pharma公司於2024年7月因違反GMP規範而收到FDA的警告，凸顯了這些挑戰。

市場機會

快速微生物檢測方法的應用

快速微生物檢測方法（RMM），例如流式細胞儀、分子檢測和自動化生長系統，正在革新無菌檢測，將檢測所需時間從數週縮短至數天，同時保持準確性。隔離機器人、閉環採樣和電子批次記錄的整合將進一步提高效率。例如，Nelson Laboratories, LLC於2025年9月推出了“RapidCert”，它將RMM與傳統生物指標相結合，提供了更快、更可靠的無菌檢測解決方案。

市場趨勢

無菌檢測服務外包增加

製藥和生物技術公司越來越多地將無菌檢測外包給專業的合約研發生產機構 (CDMO) 和合約檢測實驗室，以降低營運成本並利用先進技術。 MRPC 與 Vance Street Capital 於 2025 年 10 月簽署的策略聯盟，正體現了這種對外部檢測服務日益增長的依賴。

市場挑戰

熟練微生物學家短缺

一個主要挑戰是缺乏接受過無菌製程、隔離器操作和風險管理措施 (RMM) 驗證訓練的合格專業人員。在培訓基礎設施有限的地區，留住熟練員工是一項挑戰，這會導致工作流程效率低下和合規風險。根據 2024 年 "技能印度報告" ，製藥品質控制領域的就業率預計將為 37%，低於 46% 的全國平均。

市場區隔分析

依類型

受嚴格的監管要求和外包趨勢的推動，服務類市場將在2026年佔最大的市場佔有率，達到55.69%。試劑盒、試劑和儀器類市場也持續成長，預計年複合成長率將達7.1%。

依檢測類型

膜過濾系統將在2025年佔市場主導地位，並在2026年保持領先地位，市場佔有率將達到66.82%，這主要得益於其廣泛的應用以及符合藥典標準。

依安裝地點

外包測試領域將在2025年引領市場，並在2026年佔56.18%的市場佔有率。這主要是由於內部配備隔離器的無塵室成本高昂以及熟練勞動力短缺。

依應用領域

預計製藥業將在2025年主導市場，並在2026年維持71.92%的市佔率。這主要得益於生物製劑、生物相似藥和先進治療醫療產品（ATMP）的生產，這些產品需要進行廣泛的無菌測試。

依最終使用者

製藥和生物技術製造商在2024年引領市場，並因其高產量和嚴格的驗證要求而繼續推動成長。 CDMO/CMO預計將以8.8%的複合年增長率成長。

區域展望

北美將佔最大的市場佔有率，到2025年達到5.1億美元，並將在2026年保持領先地位，達到5.5億美元。歐洲預計到2025年將達到4億美元，而亞太地區預計到2025年將達到2.5億美元，由於藥品生產和監管投資的增加，該地區的複合年增長率將最高。 預計到 2025 年，拉丁美洲和中東及非洲的市場規模將分別達到 7,000 萬美元和 3,000 萬美元。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要疾病流行情況、主要國家和地區（2025/2026 年）
  • 無菌檢測技術進步
  • 新產品發布、主要參與者
  • 關鍵產業趨勢－併購及合作關係

第五章：全球無菌檢測市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 依類型劃分
    • 試劑盒及試劑
    • 設備
    • 服務
  • 市場分析、洞察與預測 - 依檢測類型劃分
    • 薄膜過濾系統
    • 培養及監測系統
    • 其他
  • 市場分析、洞察與預測 - 依地點劃分
    • 內部偵測
    • 外包檢測
  • 市場分析、洞察與預測 - 依應用劃分
    • 製藥
    • 醫療設備
    • 其他
  • 市場分析、洞察與預測 - 依最終用戶劃分
    • 製藥和生物技術製造商
    • 醫療器材製造商
    • CDMO/CMO 和合約檢測機構
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美無菌檢測市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲無菌檢測市場分析、洞察與預測2021-2034

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區無菌檢測市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳大利亞
    • 中國
    • 印度
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲無菌檢測市場分析、洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東和非洲無菌檢測市場分析、洞察與預測（2021-2034 年）

  • 依國家劃分
    • 南非
    • 海灣合作委員會 (GCC)
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2026 年）
  • 公司簡介
  • Merck KGaA
  • Sartorius AG
  • SKAN AG
  • Getinge AB
  • Fedegari Autoclavi S.p.A.
  • Extract Technology Limited
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • Hardy Diagnostics
  • Danaher
Product Code: FBI114440

Growth Factors of sterility testing Market

The global sterility testing market was valued at USD 1.28 billion in 2025 and is projected to grow to USD 1.38 billion in 2026, ultimately reaching USD 2.63 billion by 2034, exhibiting a CAGR of 8.4% during the forecast period. North America dominated the market in 2025, accounting for a 39.79% share, driven by extensive pharmaceutical production, strict regulatory frameworks, and technological advancements in sterility assurance.

Sterility testing is a crucial quality control process used in pharmaceuticals, biopharmaceuticals, and medical devices to ensure products are free from harmful microorganisms. The market is witnessing robust growth due to increasing biologics production, vaccines, combination products, rising regulatory emphasis on contamination prevention, and the growing adoption of rapid microbiological methods (RMMs). Key industry players such as Merck KGaA, Sartorius AG, SKAN AG, Getinge AB, and Fedegari Autoclavi S.p.A. are driving market expansion through product innovations and strategic investments.

Market Dynamics

Market Drivers

Rising Biologics Complexity and Stringent Safety Regulations

The demand for sterility testing is propelled by the increasing complexity of sterile manufacturing processes. Advanced therapies like biologics, vaccines, and ATMPs necessitate validated methods, media fills, isolator systems, and robust contamination control. Contract development and manufacturing organizations (CDMOs) are expanding capacities and implementing rapid testing methods to accelerate product release. For example, in October 2025, Eli Lilly announced over USD 1 billion investment to expand its production facility in India, supporting stricter sterility requirements.

Market Restraints

Limited Standardization and Complex Validation Procedures

Lack of globally harmonized sterility testing protocols poses challenges for manufacturers. Regulatory variations among USP, EP, and JP result in redundant validation efforts, increased costs, and delayed product release. Rapid microbiological methods require extensive equivalence and comparability studies, further complicating compliance. For instance, Brassica Pharma received an FDA warning in July 2024 for GMP violations, highlighting these challenges.

Market Opportunities

Adoption of Rapid Microbiological Methods

RMMs, including flow cytometry, molecular assays, and automated growth-based systems, are revolutionizing sterility testing by reducing timelines from weeks to days while maintaining accuracy. Integration of isolator robotics, closed-loop sampling, and electronic batch records further improves efficiency. For example, in September 2025, Nelson Laboratories, LLC launched RapidCert, combining RMMs with traditional biological indicators, offering faster and reliable sterility testing solutions.

Market Trends

Increasing Outsourcing of Sterility Testing Services

Pharmaceutical and biotech companies are increasingly outsourcing sterility testing to specialized CDMOs and contract labs to reduce operational costs and leverage advanced technologies. Strategic collaborations, such as the one between MRPC and Vance Street Capital in October 2025, reflect the growing reliance on external testing services.

Market Challenges

Shortage of Skilled Microbiologists

A significant challenge is the lack of qualified professionals trained in aseptic handling, isolator operations, and RMM validation. Regions with limited training infrastructure face difficulties retaining skilled staff, contributing to workflow inefficiencies and compliance risks. The Skill India Report 2024 highlighted a 37% employability rate in pharmaceutical quality control, below the national average of 46%.

Segmentation Analysis

By Type

The services segment held the largest share in 2026 at 55.69%, driven by strict regulatory requirements and the growing trend of outsourcing. Kits & reagents and instruments are also witnessing growth, with kits & reagents expected to grow at a CAGR of 7.1%.

By Test Type

Membrane filtration systems dominated in 2025 and are expected to maintain leadership in 2026 with 66.82% share, due to wide adoption and compliance with pharmacopeial standards.

By Site

The outsourced testing segment led the market in 2025, with 56.18% share in 2026, driven by high costs of in-house isolator-equipped cleanrooms and skilled workforce shortages.

By Application

The pharmaceutical sector dominated in 2025 and is expected to hold 71.92% share in 2026, driven by biologics, biosimilars, and ATMP production, which demand extensive sterility testing.

By End User

Pharma & biotech manufacturers led the market in 2024 and continue to drive growth due to high production volumes and strict validation requirements. CDMOs/CMOs are projected to grow at a CAGR of 8.8%.

Regional Outlook

North America held the largest share in 2025 at USD 0.51 billion and maintained leadership in 2026 at USD 0.55 billion. Europe reached USD 0.40 billion in 2025, while Asia Pacific was USD 0.25 billion in 2025 and is expected to register the fastest CAGR due to increasing pharmaceutical production and regulatory investments. Latin America and Middle East & Africa recorded USD 0.07 billion and USD 0.03 billion respectively in 2025.

Competitive Landscape

The market is semi-consolidated, dominated by Merck KGaA, Sartorius AG, SKAN AG, Getinge AB, and Fedegari Autoclavi S.p.A., focusing on strategic partnerships, product innovations, and geographic expansion. Other key players include Charles River Laboratories, Thermo Fisher Scientific, Hardy Diagnostics, and Danaher. Strategic collaborations and investments in rapid microbiological methods are central to maintaining competitive advantage.

Conclusion

The global sterility testing market is projected to grow from USD 1.38 billion in 2026 to USD 2.63 billion by 2034 at a CAGR of 8.4%. North America remains the dominant region, supported by advanced pharmaceutical production, regulatory compliance, and technology adoption, while Asia Pacific emerges as the fastest-growing market. Market growth is driven by biologics complexity, rapid microbiological methods, and the trend toward outsourcing testing services. Despite challenges like skilled labor shortages and complex validation procedures, innovations in automated sterility testing and strategic collaborations are expected to sustain robust growth through 2034.

Segmentation By Type, Test Type, Site, Application, End User, and Region

By Type * Kits & Reagents

  • Instruments
  • Services

By Test Type * Membrane Filtration Systems

  • Incubation and Monitoring Systems
  • Others

By Site * In-House Testing

  • Outsourced Testing

By Application * Pharmaceuticals

  • Medical Devices
  • Others

By End User * Pharma & Biotech Manufacturers

  • Medical Device Manufacturers
  • CDMOs/CMOs & Contract Testing Labs
  • Others

By Geography * North America (By Type, Test Type, Site, Application, End User, and Country)

    • U.S.
      • By Type
    • Canada
      • By Type
  • Europe (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
    • Germany
      • By Type
    • U.K.
      • By Type
    • France
      • By Type
    • Spain
      • By Type
    • Italy
      • By Type
    • Scandinavia
      • By Type
    • Rest of Europe
      • By Type
  • Asia Pacific (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
    • China
      • By Type
    • Japan
      • By Type
    • India
      • By Type
    • Australia
      • By Type
    • Southeast Asia
      • By Type
    • Rest of Asia Pacific
      • By Type
  • Latin America (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
    • Brazil
      • By Type
    • Mexico
      • By Type
    • Rest of Latin America
      • By Product Type
  • Middle East and Africa (By Type, Test Type, Site, Application, End User, and Country/Sub-region)
    • GCC
      • By Type
    • Saudi Arabia
      • By Type
    • Rest of Middle East and Africa
      • By Type

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. Technological Advancements in Sterility Testing
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Kits & Reagents
    • 5.1.2. Instruments
    • 5.1.3. Services
  • 5.2. Market Analysis, Insights and Forecast - By Test Type
    • 5.2.1. Membrane Filtration Systems
    • 5.2.2. Incubation and Monitoring Systems
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Site
    • 5.3.1. In-House Testing
    • 5.3.2. Outsourced Testing
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Pharmaceuticals
    • 5.4.2. Medical Devices
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Pharma & Biotech Manufacturers
    • 5.5.2. Medical Device Manufacturers
    • 5.5.3. CDMOs/CMOs & Contract Testing Labs
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East and Africa

6. North America Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Kits & Reagents
    • 6.1.2. Instruments
    • 6.1.3. Services
  • 6.2. Market Analysis, Insights and Forecast - By Test Type
    • 6.2.1. Membrane Filtration Systems
    • 6.2.2. Incubation and Monitoring Systems
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Site
    • 6.3.1. In-House Testing
    • 6.3.2. Outsourced Testing
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Pharmaceuticals
    • 6.4.2. Medical Devices
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Pharma & Biotech Manufacturers
    • 6.5.2. Medical Device Manufacturers
    • 6.5.3. CDMOs/CMOs & Contract Testing Labs
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
      • 6.6.1.1. By Type
    • 6.6.2. Canada
      • 6.6.2.1. By Type

7. Europe Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Kits & Reagents
    • 7.1.2. Instruments
    • 7.1.3. Services
  • 7.2. Market Analysis, Insights and Forecast - By Test Type
    • 7.2.1. Membrane Filtration Systems
    • 7.2.2. Incubation and Monitoring Systems
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Site
    • 7.3.1. In-House Testing
    • 7.3.2. Outsourced Testing
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Pharmaceuticals
    • 7.4.2. Medical Devices
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Pharma & Biotech Manufacturers
    • 7.5.2. Medical Device Manufacturers
    • 7.5.3. CDMOs/CMOs & Contract Testing Labs
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
      • 7.6.1.1. By Type
    • 7.6.2. Germany
      • 7.6.2.1. By Type
    • 7.6.3. France
      • 7.6.3.1. By Type
    • 7.6.4. Spain
      • 7.6.4.1. By Type
    • 7.6.5. Italy
      • 7.6.5.1. By Type
    • 7.6.6. Scandinavia
      • 7.6.6.1. By Type
    • 7.6.7. Rest of Europe
      • 7.6.7.1. By Type

8. Asia Pacific Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Kits & Reagents
    • 8.1.2. Instruments
    • 8.1.3. Services
  • 8.2. Market Analysis, Insights and Forecast - By Test Type
    • 8.2.1. Membrane Filtration Systems
    • 8.2.2. Incubation and Monitoring Systems
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Site
    • 8.3.1. In-House Testing
    • 8.3.2. Outsourced Testing
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Pharmaceuticals
    • 8.4.2. Medical Devices
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Pharma & Biotech Manufacturers
    • 8.5.2. Medical Device Manufacturers
    • 8.5.3. CDMOs/CMOs & Contract Testing Labs
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
      • 8.6.1.1. By Type
    • 8.6.2. Australia
      • 8.6.2.1. By Type
    • 8.6.3. China
      • 8.6.3.1. By Type
    • 8.6.4. India
      • 8.6.4.1. By Type
    • 8.6.5. Southeast Asia
      • 8.6.5.1. By Type
    • 8.6.6. Rest of Asia Pacific
      • 8.6.6.1. By Type

9. Latin America Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Kits & Reagents
    • 9.1.2. Instruments
    • 9.1.3. Services
  • 9.2. Market Analysis, Insights and Forecast - By Test Type
    • 9.2.1. Membrane Filtration Systems
    • 9.2.2. Incubation and Monitoring Systems
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Site
    • 9.3.1. In-House Testing
    • 9.3.2. Outsourced Testing
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Pharmaceuticals
    • 9.4.2. Medical Devices
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Pharma & Biotech Manufacturers
    • 9.5.2. Medical Device Manufacturers
    • 9.5.3. CDMOs/CMOs & Contract Testing Labs
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
      • 9.6.1.1. By Type
    • 9.6.2. Mexico
      • 9.6.2.1. By Type
    • 9.6.3. Rest of Latin America
      • 9.6.3.1. By Type

10. Middle East and Africa Sterility Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Kits & Reagents
    • 10.1.2. Instruments
    • 10.1.3. Services
  • 10.2. Market Analysis, Insights and Forecast - By Test Type
    • 10.2.1. Membrane Filtration Systems
    • 10.2.2. Incubation and Monitoring Systems
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Site
    • 10.3.1. In-House Testing
    • 10.3.2. Outsourced Testing
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Pharmaceuticals
    • 10.4.2. Medical Devices
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Pharma & Biotech Manufacturers
    • 10.5.2. Medical Device Manufacturers
    • 10.5.3. CDMOs/CMOs & Contract Testing Labs
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
      • 10.6.1.1. By Type
    • 10.6.2. GCC
      • 10.6.2.1. By Type
    • 10.6.3. Rest of Middle East and Africa
      • 10.6.3.1. By Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Merck KGaA
    • 11.2.2. Sartorius AG
    • 11.2.3. SKAN AG
    • 11.2.4. Getinge AB
    • 11.2.5. Fedegari Autoclavi S.p.A.
    • 11.2.6. Extract Technology Limited
    • 11.2.7. bioMerieux SA
    • 11.2.8. Charles River Laboratories International, Inc.
    • 11.2.9. Thermo Fisher Scientific Inc.
    • 11.2.10. Hardy Diagnostics
    • 11.2.11. Danaher

List of Tables

  • Table 1: Global Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Sterility Testing Market Revenue (USD billion) Forecast, by Test Type, 2021-2034
  • Table 3: Global Sterility Testing Market Revenue (USD billion) Forecast, by Site, 2021-2034
  • Table 4: Global Sterility Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Sterility Testing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 6: Global Sterility Testing Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: North America Sterility Testing Market Revenue (USD billion) Forecast, by Test Type, 2021-2034
  • Table 9: North America Sterility Testing Market Revenue (USD billion) Forecast, by Site, 2021-2034
  • Table 10: North America Sterility Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Sterility Testing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 12: North America Sterility Testing Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 13: U.S. Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Canada Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 15: Europe Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 16: Europe Sterility Testing Market Revenue (USD billion) Forecast, by Test Type, 2021-2034
  • Table 17: Europe Sterility Testing Market Revenue (USD billion) Forecast, by Site, 2021-2034
  • Table 18: Europe Sterility Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Europe Sterility Testing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 20: Europe Sterility Testing Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 21: UK Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Germany Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: France Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 24: Spain Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 25: Italy Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Scandinavia Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 27: Rest of Europe Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 28: Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 29: Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by Test Type, 2021-2034
  • Table 30: Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by Site, 2021-2034
  • Table 31: Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 32: Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 33: Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 34: Japan Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 35: Australia Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 36: China Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 37: India Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 38: South East Asia Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 39: Rest of Asia Pacific Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 40: Latin America Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 41: Latin America Sterility Testing Market Revenue (USD billion) Forecast, by Test Type, 2021-2034
  • Table 42: Latin America Sterility Testing Market Revenue (USD billion) Forecast, by Site, 2021-2034
  • Table 43: Latin America Sterility Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 44: Latin America Sterility Testing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 45: Latin America Sterility Testing Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 46: Brazil Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 47: Mexico Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 48: Rest of Latin America Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 49: Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 50: Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by Test Type, 2021-2034
  • Table 51: Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by Site, 2021-2034
  • Table 52: Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 53: Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 54: Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 55: GCC Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 56: South Africa Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 57: Rest of Middle East and Africa Sterility Testing Market Revenue (USD billion) Forecast, by Type, 2021-2034

List of Figures

  • Figure 1: Global Sterility Testing Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
  • Figure 2: Global Sterility Testing Market Value Share (%), by Type, 2026 & 2034
  • Figure 3: Global Sterility Testing Market Value Share (%), by Test Type, 2026 & 2034
  • Figure 4: Global Sterility Testing Market Value Share (%), by Site, 2026 & 2034
  • Figure 5: Global Sterility Testing Market Value Share (%), by Application, 2026 & 2034
  • Figure 6: Global Sterility Testing Market Value Share (%), by End-user, 2026 & 2034
  • Figure 7: Global Sterility Testing Market Value (USD billion), by Region, 2026 & 2034
  • Figure 8: North America Sterility Testing Market Value (USD billion), by Type, 2026 & 2034
  • Figure 9: North America Sterility Testing Market Value Share (%), by Type, 2026
  • Figure 10: North America Sterility Testing Market Value (USD billion), by Test Type, 2026 & 2034
  • Figure 11: North America Sterility Testing Market Value Share (%), by Test Type, 2026
  • Figure 12: North America Sterility Testing Market Value (USD billion), by Site, 2026 & 2034
  • Figure 13: North America Sterility Testing Market Value Share (%), by Site, 2026
  • Figure 14: North America Sterility Testing Market Value (USD billion), by Application, 2026 & 2034
  • Figure 15: North America Sterility Testing Market Value Share (%), by Application, 2026
  • Figure 16: North America Sterility Testing Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 17: North America Sterility Testing Market Value Share (%), by End-user, 2026
  • Figure 18: North America Sterility Testing Market Value (USD billion), By Country, 2026 & 2034
  • Figure 19: North America Sterility Testing Market Value Share (%), By Country, 2026
  • Figure 20: Europe Sterility Testing Market Value (USD billion), by Type, 2026 & 2034
  • Figure 21: Europe Sterility Testing Market Value Share (%), by Type, 2026
  • Figure 22: Europe Sterility Testing Market Value (USD billion), by Test Type, 2026 & 2034
  • Figure 23: Europe Sterility Testing Market Value Share (%), by Test Type, 2026
  • Figure 24: Europe Sterility Testing Market Value (USD billion), by Site, 2026 & 2034
  • Figure 25: Europe Sterility Testing Market Value Share (%), by Site, 2026
  • Figure 26: Europe Sterility Testing Market Value (USD billion), by Application, 2026 & 2034
  • Figure 27: Europe Sterility Testing Market Value Share (%), by Application, 2026
  • Figure 28: Europe Sterility Testing Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 29: Europe Sterility Testing Market Value Share (%), by End-user, 2026
  • Figure 30: Europe Sterility Testing Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 31: Europe Sterility Testing Market Value Share (%), By Country/Sub-region, 2026
  • Figure 32: Asia Pacific Sterility Testing Market Value (USD billion), by Type, 2026 & 2034
  • Figure 33: Asia Pacific Sterility Testing Market Value Share (%), by Type, 2026
  • Figure 34: Asia Pacific Sterility Testing Market Value (USD billion), by Test Type, 2026 & 2034
  • Figure 35: Asia Pacific Sterility Testing Market Value Share (%), by Test Type, 2026
  • Figure 36: Asia Pacific Sterility Testing Market Value (USD billion), by Site, 2026 & 2034
  • Figure 37: Asia Pacific Sterility Testing Market Value Share (%), by Site, 2026
  • Figure 38: Asia Pacific Sterility Testing Market Value (USD billion), by Application, 2026 & 2034
  • Figure 39: Asia Pacific Sterility Testing Market Value Share (%), by Application, 2026
  • Figure 40: Asia Pacific Sterility Testing Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 41: Asia Pacific Sterility Testing Market Value Share (%), by End-user, 2026
  • Figure 42: Asia Pacific Sterility Testing Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 43: Asia Pacific Sterility Testing Market Value Share (%), By Country/Sub-region, 2026
  • Figure 44: Latin America Sterility Testing Market Value (USD billion), by Type, 2026 & 2034
  • Figure 45: Latin America Sterility Testing Market Value Share (%), by Type, 2026
  • Figure 46: Latin America Sterility Testing Market Value (USD billion), by Test Type, 2026 & 2034
  • Figure 47: Latin America Sterility Testing Market Value Share (%), by Test Type, 2026
  • Figure 48: Latin America Sterility Testing Market Value (USD billion), by Site, 2026 & 2034
  • Figure 49: Latin America Sterility Testing Market Value Share (%), by Site, 2026
  • Figure 50: Latin America Sterility Testing Market Value (USD billion), by Application, 2026 & 2034
  • Figure 51: Latin America Sterility Testing Market Value Share (%), by Application, 2026
  • Figure 52: Latin America Sterility Testing Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 53: Latin America Sterility Testing Market Value Share (%), by End-user, 2026
  • Figure 54: Latin America Sterility Testing Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 55: Latin America Sterility Testing Market Value Share (%), By Country/Sub-region, 2026
  • Figure 44: Middle East and Africa Sterility Testing Market Value (USD billion), by Type, 2026 & 2034
  • Figure 45: Middle East and Africa Sterility Testing Market Value Share (%), by Type, 2026
  • Figure 46: Middle East and Africa Sterility Testing Market Value (USD billion), by Test Type, 2026 & 2034
  • Figure 47: Middle East and Africa Sterility Testing Market Value Share (%), by Test Type, 2026
  • Figure 48: Middle East and Africa Sterility Testing Market Value (USD billion), by Site, 2026 & 2034
  • Figure 49: Middle East and Africa Sterility Testing Market Value Share (%), by Site, 2026
  • Figure 50: Middle East and Africa Sterility Testing Market Value (USD billion), by Application, 2026 & 2034
  • Figure 51: Middle East and Africa Sterility Testing Market Value Share (%), by Application, 2026
  • Figure 52: Middle East and Africa Sterility Testing Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 53: Middle East and Africa Sterility Testing Market Value Share (%), by End-user, 2026
  • Figure 54: Middle East and Africa Sterility Testing Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 55: Middle East and Africa Sterility Testing Market Value Share (%), By Country/Sub-region, 2026
  • Figure 56: Global Sterility Testing Market Share (%), By Company, 2026